Byetta, Januvia, Janumet, and Victoza

Prescription drugs Januvia, Janumet, Byetta and Victoza are popular Type 2 diabetes treatments, but reports of dangerous side effects including pancreatitis and pancreatic cancer raise questions about whether the drugs’ risks outweigh their benefits. Many people who have suffered from these side effects have filed lawsuits against the makers of these drugs, Merck (Januvia and Janumet), Amylin, Eli Lilly and Bristol-Myers Squibb (Byetta), and Novo Nordisk A/S (Victoza).

The U.S. Food and Drug Administration approved Byetta, Januvia, Janumet and Victoza in 2005, 2006, 2007 and 2010, respectively. These drugs are classified as incretin mimetics. Since approving them, the FDA has issued warnings linking the drugs to serious complications such as pancreatic diseases, yet these products  remain on the market, putting patients at risk.

Lawsuits allege that the drugmakers marketed these medications despite knowing that they were dangerous and failed to warn the public about the risk of pancreatic cancer and pancreatitis. If you or a loved one has suffered dangerous side effects from Januvia, Janumet, Byetta or Victoza, you may be eligible for compensation for your injuries.  We are currently investigating claims of pancreatic and thyroid cancer.
Status of Januvia and Byetta Lawsuits
Since hitting the market, the four diabetes treatments were prescribed to millions of people in the United States. Many people developed pancreatic diseases and filed lawsuits against the drugs’ manufacturers. A significant number of cases may ultimately be filed in state and federal courts across the country.

In fact, so many were filed in California that a federal court streamlined case procedures there. The U.S. District Court for the Southern District of California grouped hundreds of Januvia and Byetta personal injury cases together for discovery. The cases were filed against Januvia maker Merck & Co., Inc., and various Merck affiliates, as well as the makers and marketers of Byetta, Amylin Pharmaceuticals and Eli Lilly and Company. In 2012, Bristol-Myers Squibb purchased Amylin for about $5.3 billion, adding them to the list of possible defendants for Byetta lawsuits. The plaintiffs allege that use of Januvia and Byetta led to pancreatic cancer.

Some of the cases were originally filed in state court before being moved to federal court. Defendants who expect a lot of similar lawsuits often request removal to federal court to help them manage their litigation efficiently.

Meanwhile, similar personal injury claims began to emerge against Janumet and Victoza. In August 2013, a federal judicial panel decided to centralize federal cases involving all four drugs in the Southern District of California. Judge Anthony J. Battaglia presides over the cases, which are collectively known as In Re: Incretin Mimetics Products Liability Litigation (MDL No. 2452).

In its order, the panel noted that it usually avoids centralizing cases involving competitors. But in this instance, it found that the allegations against the four drugs were “highly similar.” In fact many of the plaintiffs took more than one of the drugs and will likely call the same witnesses. The panel also found it compelling that all defendants supported centralization.

As of March 2014, 325 cases were pending in MDL 2452. Additional lawsuits are expected to be filed in federal court as well as California and other state courts. New Jersey may also emerge as a popular venue for case filing since it is the location of Merck’s headquarters.

Why Should You File a Incretin Mimetics Products Liability Lawsuit?
In January 2013, an Ohio woman filed a lawsuit against Merck and Amylin, alleging that Byetta and Januvia caused her father’s death. Diabetes treatments were prescribed to Robin Raesky’s father as early as 2007. He was diagnosed with pancreatic cancer in 2011. Robin is one of an increasing number of plaintiffs who allege that the drugmakers failed to “exercise reasonable care” and created “unreasonable risks of personal injury to others.”

These plaintiffs also allege that Merck, Amylin and Eli Lilly and Novo Nordisk A/S knew or should have known that the drugs created “a high risk of unreasonable, dangerous side effects, including causing and increasing the risk of developing pancreatic cancer.” As a result, claimants have suffered “grievous bodily injury, and untimely death,” along with other losses.

Use of Januvia, Janumet, Byetta and Victoza is associated with acute pancreatitis, including hemorrhagic pancreatitis or necrotizing pancreatitis, which are often fatal.

People who develop these conditions after using one of these drugs may suffer from the following:
Inflammation of the pancreas
Severe abdominal and back pain
Abnormal blood pressure
Elevated heart or respiratory rates
Nausea or vomiting

These injuries may persist after patients discontinue use of the prescription drugs. In addition, the drugs may increase the risk for developing pancreatic cancer. Byetta is also linked to various types of kidney dysfunction, with some reports of thyroid cancer.

Patients who are injured are left with new health concerns in addition to their diabetes. Treating severe side effects from these drugs requires long-term medical care and, in many cases, hospitalization. Although financial compensation cannot undo all of the harm injured patients may suffer, it can help them cover medical expenses and replace income lost from an inability to work.

Examples of relief sought by plaintiffs include:
Past and future medical expenses
Home health care
Past and future lost earnings
Pain and suffering

When available, plaintiffs also seek punitive damages to discourage the drugmakers from future wrongdoing. Loved ones may also file lawsuits to obtain compensation for their pain and suffering. Survivors of patients who die because of their injuries may be eligible to file wrongful death claims.

People Who Filed Victoza, Janumet, Januvia and Byetta Lawsuits
People who filed lawsuits claim the drugmakers “overpromoted and underwarned.” In addition to an increasing number of lawsuits, Merck, Amylin, Eli Lilly and Novo Nordisk A/S incurred criticism because patients and physicians were not adequately warned about serious, potentially fatal, health risks. Had they received adequate warnings, many of the patients who developed pancreatic cancer or acute pancreatitis could have chosen other diabetes treatments.



If you or a loved one has been injured by Januvia, Janumet, Byetta or Victoza, you may be eligible for compensation for your injuries. A qualified attorney can help you file a claim for injuries caused by one or more of the drugs. Please call or contact our office today at 727-397-9198 for a free consultation.
727-397-9198 9am-5pm / Mon.-Thu.